티움바이오

321550KOSDAQ자연과학 및 공학 연구개발업

52.4 / 100

Reference Date: 2026-07-24

Financial Score16.0 / 40

News Sentiment20.4 / 25

Momentum6.0 / 20

Disclosure10.0 / 15

AI Analysis: the high debt ratio poses financial risk, ROE is below the industry average. Declined 5.8% over the past month, and news sentiment is positive.

Company InformationBased on 2025 Annual Report

Business Overview

Tium Bio is a biopharmaceutical company founded by a team that successfully developed and licensed the FDA-approved hemophilia treatment Afstyla, focusing on R&D for rare and intractable diseases. The company develops both small-molecule synthetic drugs and biopharmaceuticals, with several drug candidates in clinical trials, including NCE401 and NBP604. In 2024, Tium Bio acquired Petraon Care Lab, a natural cosmetics OEM/ODM firm, and operates Protiom Science, a CDAO company providing specialized biopharmaceutical process development services.

Number of Employees

67people

Average Salary

57.4M KRW

Score Calculation Basis

Detailed Financial Score

PER

—Industry Average 43.644.0Point

PBR

3.20Industry Average 2.522.5Point

Higher than industry avg (caution)

ROE

-42.45Industry Average -32.093.5Point

In line with industry avg

Debt Ratio

39.36Industry Average 7.310.0Point

5.4x industry avg (risky)

Trend 2023~20256.0 / 10 points

Revenue Growth Rate

3.0 / 3

Avg ▲59.8% (2-year basis)

Operating Profit Growth Rate

3.0 / 3

Avg ▲23.2% (2-year basis)

ROE Trend

0.0 / 4

Avg ROE -36.7% (declining, 3yr)

Detailed News Sentiment

3 totalPositive 3Neutral 0Negative 0Average Sentiment Score 81.7

Positive
티움바이오 토스포서팁, TGF-β ‘임상 무덤’에서도 살아남을 수 있는...
티움바이오의 TGF-β 차단 치료제 토스포서팁이 임상 진행 속도를 높이며 계열 내 최초 신약 개발에 진전을 보이고 있다.
Positive
티움바이오 김훈택 대표, 자사주 7만주 장내 매수 [공시록]
티움바이오의 김훈택 대표이사가 자사주를 매수함으로써 회사의 핵심 신약 개발에 대한 강한 의지를 보여주며 긍정적인 시장 반응을 이끌어냈다.
Positive
티움바이오, 김훈택 대표 약 3억원 규모 장내 매수…파이프라인 성장....
티움바이오 대표의 대규모 주식 매수로 회사 파이프라인 성장에 대한 긍정적 전망이 반영되었다.

Detailed Momentum

52-week position1.0Point

Near 52w low (3%, downtrend)

Current 4,020Won52-week high 13,14052-week low 3,685

1-month return2.0Point

1m -5.85% (slight drop)

Volume trend3.0Point

Volume flat

Detailed Disclosure

0 totalPositive 0Neutral 0Negative 0